<DOC>
	<DOCNO>NCT02349399</DOCNO>
	<brief_summary>The study objective characterize new user Cyproterone Acetate / Ethinylestradiol ( CPA/EE ) 2011/2012 2014 accord demographic , treatment characteristic , previous diagnosis acne , hirsutism hyperandrogenic condition , previous acne treatment ( concomitant ) use hormonal contraceptive identify Healthcare Databases UK ( THIN ) , Netherlands ( PHARMO ) Italy ( HSD ) .</brief_summary>
	<brief_title>Drug Utilization Study Diane-35 ( Generics ) Three European Healthcare Databases</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Cyproterone acetate , ethinyl estradiol drug combination</mesh_term>
	<mesh_term>Cyproterone</mesh_term>
	<mesh_term>Cyproterone Acetate</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<criteria>The study population include female patient register investigated healthcare databases receive CPA/EE 2011 2012 ( first run ) 2014 ( second run ) , without prescription CPA/EE year prior index date . Only patient record history database â‰¥ 365 day prior index date include study . &lt; 365 day record history database prior index date prescription CPA/EE year prior index date</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>